Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia

A universally available prognostic test

Grzegorz S Nowakowski, James Hoyer, Tait D. Shanafelt, Susan M. Geyer, Betsy R. LaPlant, Timothy G. Call, Diane F Jelinek, Clive S. Zent, Neil Elliot Kay

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Recently developed prognostic tests in early Rai and Binet stage chronic lymphocytlc leukemia (CLL) require considerable technologic expertise and are not available worldwide. Smudge cells are CLL ceils raptured during smear preparation. We hypothesized that smudge cell formation is inversely correlated with expression of vimentin, a cytoskeletal protein and prognostic marker, and that the percentage of smudge cells woyld predict prognosis in CLL. We reviewed the blood smears of 75 patients with previously untreated early- and intermediate-stage CLL (Rai stage 0-II) who were seen at the Mayo Clinic in Rochester, Minn, between September 1939 and December 2000. A total of 200 lymphocytes and smudge cells were counted on each slide and the results expressed as a percentage of the total lymphocytes (Intact and smudged). The median percentage of smudge cells was 27% (range, 4%-72%). The percentage of smudge cells inversely correlated with vimentin expression (r=-0.57; P=.007). The median percentage of smudge cells was higher in patients with the mutated immunoglobulin heavy chain gene than. In those with the unmutated immunoglobulin heavy chain gene (31% vs 13%; P=.02). Patients with less than 30% smudge cells had a median time from diagnosis to initial treatment of 72.7 months, whereas the median time from diagnosis to initial treatment in patients with 30% or more smudge cells was not reached (P=.001). The percentage of smudge cells as a continuous variable correlated with overall survival (P=.04). The estimation of smudge cells on a blood smear could be a universally available prognostic test in early-stage CLL.

Original languageEnglish (US)
Pages (from-to)449-453
Number of pages5
JournalMayo Clinic Proceedings
Volume82
Issue number4
DOIs
StatePublished - 2007

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Leukemia
Immunoglobulin Heavy Chain Genes
Vimentin
Lymphocytes
Cytoskeletal Proteins
Survival

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia : A universally available prognostic test. / Nowakowski, Grzegorz S; Hoyer, James; Shanafelt, Tait D.; Geyer, Susan M.; LaPlant, Betsy R.; Call, Timothy G.; Jelinek, Diane F; Zent, Clive S.; Kay, Neil Elliot.

In: Mayo Clinic Proceedings, Vol. 82, No. 4, 2007, p. 449-453.

Research output: Contribution to journalArticle

@article{ab490b58633847b5b82020248ade9fbc,
title = "Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: A universally available prognostic test",
abstract = "Recently developed prognostic tests in early Rai and Binet stage chronic lymphocytlc leukemia (CLL) require considerable technologic expertise and are not available worldwide. Smudge cells are CLL ceils raptured during smear preparation. We hypothesized that smudge cell formation is inversely correlated with expression of vimentin, a cytoskeletal protein and prognostic marker, and that the percentage of smudge cells woyld predict prognosis in CLL. We reviewed the blood smears of 75 patients with previously untreated early- and intermediate-stage CLL (Rai stage 0-II) who were seen at the Mayo Clinic in Rochester, Minn, between September 1939 and December 2000. A total of 200 lymphocytes and smudge cells were counted on each slide and the results expressed as a percentage of the total lymphocytes (Intact and smudged). The median percentage of smudge cells was 27{\%} (range, 4{\%}-72{\%}). The percentage of smudge cells inversely correlated with vimentin expression (r=-0.57; P=.007). The median percentage of smudge cells was higher in patients with the mutated immunoglobulin heavy chain gene than. In those with the unmutated immunoglobulin heavy chain gene (31{\%} vs 13{\%}; P=.02). Patients with less than 30{\%} smudge cells had a median time from diagnosis to initial treatment of 72.7 months, whereas the median time from diagnosis to initial treatment in patients with 30{\%} or more smudge cells was not reached (P=.001). The percentage of smudge cells as a continuous variable correlated with overall survival (P=.04). The estimation of smudge cells on a blood smear could be a universally available prognostic test in early-stage CLL.",
author = "Nowakowski, {Grzegorz S} and James Hoyer and Shanafelt, {Tait D.} and Geyer, {Susan M.} and LaPlant, {Betsy R.} and Call, {Timothy G.} and Jelinek, {Diane F} and Zent, {Clive S.} and Kay, {Neil Elliot}",
year = "2007",
doi = "10.4065/82.4.449",
language = "English (US)",
volume = "82",
pages = "449--453",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "4",

}

TY - JOUR

T1 - Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia

T2 - A universally available prognostic test

AU - Nowakowski, Grzegorz S

AU - Hoyer, James

AU - Shanafelt, Tait D.

AU - Geyer, Susan M.

AU - LaPlant, Betsy R.

AU - Call, Timothy G.

AU - Jelinek, Diane F

AU - Zent, Clive S.

AU - Kay, Neil Elliot

PY - 2007

Y1 - 2007

N2 - Recently developed prognostic tests in early Rai and Binet stage chronic lymphocytlc leukemia (CLL) require considerable technologic expertise and are not available worldwide. Smudge cells are CLL ceils raptured during smear preparation. We hypothesized that smudge cell formation is inversely correlated with expression of vimentin, a cytoskeletal protein and prognostic marker, and that the percentage of smudge cells woyld predict prognosis in CLL. We reviewed the blood smears of 75 patients with previously untreated early- and intermediate-stage CLL (Rai stage 0-II) who were seen at the Mayo Clinic in Rochester, Minn, between September 1939 and December 2000. A total of 200 lymphocytes and smudge cells were counted on each slide and the results expressed as a percentage of the total lymphocytes (Intact and smudged). The median percentage of smudge cells was 27% (range, 4%-72%). The percentage of smudge cells inversely correlated with vimentin expression (r=-0.57; P=.007). The median percentage of smudge cells was higher in patients with the mutated immunoglobulin heavy chain gene than. In those with the unmutated immunoglobulin heavy chain gene (31% vs 13%; P=.02). Patients with less than 30% smudge cells had a median time from diagnosis to initial treatment of 72.7 months, whereas the median time from diagnosis to initial treatment in patients with 30% or more smudge cells was not reached (P=.001). The percentage of smudge cells as a continuous variable correlated with overall survival (P=.04). The estimation of smudge cells on a blood smear could be a universally available prognostic test in early-stage CLL.

AB - Recently developed prognostic tests in early Rai and Binet stage chronic lymphocytlc leukemia (CLL) require considerable technologic expertise and are not available worldwide. Smudge cells are CLL ceils raptured during smear preparation. We hypothesized that smudge cell formation is inversely correlated with expression of vimentin, a cytoskeletal protein and prognostic marker, and that the percentage of smudge cells woyld predict prognosis in CLL. We reviewed the blood smears of 75 patients with previously untreated early- and intermediate-stage CLL (Rai stage 0-II) who were seen at the Mayo Clinic in Rochester, Minn, between September 1939 and December 2000. A total of 200 lymphocytes and smudge cells were counted on each slide and the results expressed as a percentage of the total lymphocytes (Intact and smudged). The median percentage of smudge cells was 27% (range, 4%-72%). The percentage of smudge cells inversely correlated with vimentin expression (r=-0.57; P=.007). The median percentage of smudge cells was higher in patients with the mutated immunoglobulin heavy chain gene than. In those with the unmutated immunoglobulin heavy chain gene (31% vs 13%; P=.02). Patients with less than 30% smudge cells had a median time from diagnosis to initial treatment of 72.7 months, whereas the median time from diagnosis to initial treatment in patients with 30% or more smudge cells was not reached (P=.001). The percentage of smudge cells as a continuous variable correlated with overall survival (P=.04). The estimation of smudge cells on a blood smear could be a universally available prognostic test in early-stage CLL.

UR - http://www.scopus.com/inward/record.url?scp=34047199677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34047199677&partnerID=8YFLogxK

U2 - 10.4065/82.4.449

DO - 10.4065/82.4.449

M3 - Article

VL - 82

SP - 449

EP - 453

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 4

ER -